12.05.2011 • NewsPotashK+Sfertilizer

K+S Says Compo Unit Could Be Sold At End Of June

German potash miner K+S  is making progress in the planned sale of its garden fertilizer unit Compo and is aiming to strike a deal at the end of next month as it focuses on its main salt and potash units.

The sales process would move from the second phase to the final stage this month, and an agreement could be struck as early as end-June, the head of K+S's fertilizer unit Joachim Felker said at the group's annual shareholder meeting on Wednesday.

"There are several (potential) buyers. We want to conclude this process as soon as possible," Felker said.

The world's fourth-largest potash miner hired Goldman Sachs for a strategic review of the unit in June of last year. Compo makes about €400 million ($576 million) in annual sales from specialty fertilizers and potting soil for garden plants.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.